Skip to main content
    M

    Medtronic PLC (MDT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $102.90
    +0.04 (+0.04%)

    Market Cap: $131.57B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Medtronic PLC (MDT) Financials: Revenue, Profit and Cash Flow

    Updated Sep 1, 2026. Financial statements from company filings, amounts in US dollars.

    Medtronic reported revenue of $36.36B for the fiscal year ended Apr 30, 2026, up 8.4% from the year before. That year, net income was $4.84B with a net margin of 13.3%, operating cash flow was $7.33B and free cash flow was $5.43B. The quarter ended Jul 31, 2026 had revenue of $9.76B and net income of $1.48B.

    Revenue and Margins

    The operating margin was 17.8% in the fiscal year ended Apr 2026. Over the 9 years to Apr 2026, revenue grew from $29.71B, a compound annual rate of 2.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Apr 2026$36.36B+8.4%65.0%17.8%13.3%
    Apr 2025$33.54B+3.6%65.3%17.8%14.0%
    Apr 2024$32.36B+3.6%65.3%15.9%11.4%
    Apr 2023$31.23B-1.4%65.7%17.6%12.1%
    Apr 2022$31.69B+5.2%68.0%18.2%16.0%
    Apr 2021$30.12B+4.2%65.2%14.9%12.1%
    Apr 2020$28.91B-5.4%67.4%16.6%16.6%
    Apr 2019$30.56B+2.0%70.0%20.5%15.2%
    Apr 2018$29.95B+0.8%69.7%22.2%10.3%
    Apr 2017$29.71BN/A68.7%18.1%13.5%
    Annual, fiscal years ended Apr 2017 to Apr 2026

    Income Statement

    In the fiscal year ended Apr 2026, net income rose 3.2% from the year before. In the quarter ended Jul 2026, net income rose 41.0% from the same quarter a year earlier.

    Annual

    Line itemApr 2026Apr 2025Apr 2024Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017
    Revenue$36.36B$33.54B$32.36B$31.23B$31.69B$30.12B$28.91B$30.56B$29.95B$29.71B
    Cost of revenue$12.72B$11.63B$11.22B$10.72B$10.14B$10.48B$9.42B$9.15B$9.07B$9.29B
    Gross profit$23.64B$21.91B$21.15B$20.51B$21.54B$19.63B$19.49B$21.40B$20.89B$20.42B
    Research and development$2.87B$2.73B$2.73B$2.70B$2.75B$2.49B$2.33B$2.33B$2.26B$2.19B
    Operating income$6.47B$5.96B$5.14B$5.49B$5.75B$4.48B$4.79B$6.27B$6.64B$5.38B
    Net income$4.84B$4.69B$3.71B$3.78B$5.06B$3.63B$4.81B$4.65B$3.10B$4.02B
    EBITDA$9.81B$9.22B$8.20B$8.70B$8.78B$7.52B$7.81B$9.30B$9.46B$8.61B
    Fiscal years ended Apr 2017 to Apr 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Revenue$9.76B$9.81B$9.02B$8.96B$8.58B$8.93B$8.29B$8.40B$7.92B$8.59B$8.09B$7.98B
    Gross profit$6.34B$6.41B$5.76B$5.90B$5.58B$5.78B$5.51B$5.46B$5.15B$5.54B$5.31B$5.22B
    Operating income$1.76B$1.87B$1.46B$1.69B$1.45B$1.44B$1.65B$1.59B$1.28B$1.05B$1.48B$1.34B
    Net income$1.48B$1.26B$1.15B$1.38B$1.05B$1.06B$1.30B$1.28B$1.05B$660.00M$1.34B$911.00M
    Last 12 quarters

    Balance Sheet

    As of Apr 2026, total debt of $27.96B exceeded cash and equivalents by $26.01B.

    Annual

    Line itemApr 2026Apr 2025Apr 2024Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017
    Total assets$93.03B$91.68B$89.98B$90.95B$90.98B$93.08B$90.69B$89.69B$91.39B$99.86B
    Current assets$24.79B$23.81B$21.93B$21.68B$23.06B$22.55B$22.03B$21.97B$22.98B$24.87B
    Cash and equivalents$1.95B$2.22B$1.28B$1.54B$3.71B$3.59B$4.14B$4.39B$3.67B$4.97B
    Total liabilities$42.96B$43.42B$39.56B$39.28B$38.26B$41.48B$39.82B$39.48B$40.57B$49.53B
    Short-term debt$1.79B$2.87B$1.09B$20.00M$3.74B$11.00M$2.78B$838.00M$2.06B$7.52B
    Long-term debt$26.17B$25.64B$23.93B$24.34B$20.37B$26.38B$22.02B$24.49B$23.70B$25.92B
    Shareholder equity$49.46B$48.02B$50.21B$51.48B$52.55B$51.43B$50.74B$50.09B$50.72B$50.21B
    Fiscal years ended Apr 2017 to Apr 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Total assets$93.31B$93.03B$91.48B$91.35B$90.97B$91.68B$89.97B$90.04B$89.75B$89.98B$90.84B$90.09B
    Total liabilities$42.46B$42.96B$42.29B$42.49B$42.84B$43.42B$40.36B$41.33B$41.59B$39.56B$38.84B$38.44B
    Cash and equivalents$1.69B$1.95B$1.15B$1.28B$1.27B$2.22B$1.24B$1.39B$1.31B$1.28B$1.62B$1.31B
    Shareholder equity$50.23B$49.46B$48.98B$48.65B$47.89B$48.02B$49.39B$48.49B$47.95B$50.21B$51.79B$51.46B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Apr 2026, free cash flow was 74.1% of operating cash flow. Dividends and share repurchases together came to 86.0% of it.

    Annual

    Line itemApr 2026Apr 2025Apr 2024Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017
    Operating cash flow$7.33B$7.04B$6.79B$6.04B$7.35B$6.24B$7.23B$7.01B$4.68B$6.88B
    Capital expenditures$1.90B$1.86B$1.59B$1.46B$1.37B$1.35B$1.21B$1.13B$1.07B$1.25B
    Free cash flow$5.43B$5.18B$5.20B$4.58B$5.98B$4.88B$6.02B$5.87B$3.62B$5.63B
    Dividends paid$3.64B$3.59B$3.67B$3.62B$3.38B$3.12B$2.89B$2.69B$2.49B$2.38B
    Share repurchases$1.03B$3.23B$2.14B$645.00M$2.54B$652.00M$1.33B$2.88B$2.17B$3.54B
    Investing cash flow-$2.93B-$1.94B-$2.37B-$3.49B-$1.66B-$2.87B-$3.20B-$774.00M$5.86B-$1.57B
    Financing cash flow-$4.75B-$4.36B-$4.45B-$4.96B-$5.34B-$4.14B-$4.20B-$5.43B-$11.95B-$3.28B
    Fiscal years ended Apr 2017 to Apr 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Operating cash flow$1.79B$2.57B$2.74B$925.00M$1.09B$2.53B$2.57B$958.00M$986.00M$2.78B$2.47B$661.00M
    Capital expenditures$503.00M$488.00M$444.00M$468.00M$504.00M$459.00M$476.00M$404.00M$520.00M$426.00M$346.00M$461.00M
    Free cash flow$1.29B$2.08B$2.30B$457.00M$584.00M$2.07B$2.10B$554.00M$466.00M$2.35B$2.13B$200.00M
    Last 12 quarters

    Frequently Asked Questions About MDT

    What is Medtronic's annual revenue?

    Medtronic reported revenue of $36.36B for the fiscal year ended Apr 30, 2026.

    How fast is Medtronic's revenue growing?

    Revenue was up 8.4% for the fiscal year ended Apr 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 5.2%.

    Is Medtronic profitable?

    Yes. Medtronic reported net income of $4.84B for the fiscal year ended Apr 30, 2026, with a net margin of 13.3%.

    How much free cash flow does MDT generate?

    For the fiscal year ended Apr 30, 2026, operating cash flow of $7.33B minus capital expenditures of $1.90B produced free cash flow of $5.43B.

    How much debt does Medtronic have?

    The balance sheet dated Apr 30, 2026 reported long-term debt of $26.17B, short-term debt of $1.79B and cash and equivalents of $1.95B.